Profile data is unavailable for this security.
About the company
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
- Revenue in USD (TTM)12.54m
- Net income in USD-28.59m
- Incorporated2016
- Employees37.00
- LocationLAVA Therapeutics NVYalelaan 60UTRECHT 3584 CMNetherlandsNLD
- Phone+31 30003035
- Websitehttps://www.lavatherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lantern Pharma Inc | 0.00 | -17.53m | 47.55m | 21.00 | -- | 1.33 | -- | -- | -1.62 | -1.62 | 0.00 | 3.32 | 0.00 | -- | -- | 0.00 | -36.82 | -28.83 | -39.63 | -30.17 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.93 | -- | -- | -- |
Protara Therapeutics Inc | 0.00 | -42.47m | 47.77m | 26.00 | -- | 0.4542 | -- | -- | -3.74 | -3.74 | 0.00 | 5.11 | 0.00 | -- | -- | 0.00 | -48.67 | -37.02 | -52.23 | -38.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 38.71 | -- | -17.67 | -- |
Kezar Life Sciences Inc | 7.00m | -101.33m | 48.13m | 58.00 | -- | 0.2846 | -- | 6.88 | -1.39 | -1.39 | 0.0963 | 2.32 | 0.029 | -- | -- | 120,689.70 | -41.93 | -32.54 | -44.69 | -34.09 | -- | -- | -1,447.56 | -4,308.11 | -- | -- | 0.0565 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
Marker Therapeutics Inc | 3.32m | -12.21m | 48.16m | 8.00 | -- | 4.08 | -- | 14.50 | -1.38 | -0.636 | 0.3751 | 1.32 | 0.158 | -- | 1.69 | 415,107.50 | -58.12 | -53.74 | -70.75 | -62.25 | -- | -- | -367.79 | -1,438.71 | -- | -- | 0.00 | -- | -5.76 | 74.27 | 28.97 | -- | -- | -- |
Angion Biomedica Corp | 0.00 | -38.99m | 48.56m | 32.00 | -- | 9.51 | -- | -- | -6.63 | -6.63 | 0.00 | 0.4765 | 0.00 | -- | -- | 0.00 | -117.72 | -105.91 | -133.85 | -331.69 | -- | -- | -- | -712.81 | -- | -- | 0.00 | -- | -100.00 | -- | 9.31 | -- | -- | -- |
Atara Biotherapeutics Inc | 34.70m | -233.11m | 49.24m | 173.00 | -- | -- | -- | 1.42 | -52.93 | -52.93 | 7.54 | -20.43 | 0.1485 | 0.9947 | 1.92 | 154,240.00 | -99.76 | -70.20 | -213.09 | -86.94 | 69.30 | -- | -671.70 | -1,559.33 | 0.50 | -- | -- | -- | -86.51 | -- | -20.95 | -- | -49.14 | -- |
Reneo Pharmaceuticals Inc | 0.00 | -70.71m | 50.13m | 8.00 | -- | 0.6171 | -- | -- | -2.17 | -2.17 | 0.00 | 2.43 | 0.00 | -- | -- | 0.00 | -77.06 | -- | -83.08 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -48.95 | -- | -- | -- |
Passage Bio Inc | 0.00 | -84.44m | 51.06m | 58.00 | -- | 0.4866 | -- | -- | -1.53 | -1.53 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -47.73 | -48.56 | -52.17 | -52.09 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.02 | -- | -43.53 | -- |
DURECT Corp | 8.32m | -23.28m | 51.68m | 48.00 | -- | 6.23 | -- | 6.21 | -0.8653 | -0.8653 | 0.2976 | 0.2674 | 0.176 | 0.7021 | 6.87 | 143,465.50 | -49.23 | -37.34 | -167.81 | -53.44 | 80.56 | 91.83 | -279.77 | -139.11 | 0.9575 | -47.70 | 0.6377 | -- | -55.67 | -10.96 | 21.82 | -- | -10.98 | -- |
LAVA Therapeutics NV | 12.54m | -28.59m | 52.05m | 37.00 | -- | 1.03 | -- | 4.15 | -1.07 | -1.07 | 0.4668 | 1.93 | 0.107 | -- | 9.09 | 338,837.80 | -24.40 | -- | -28.91 | -- | 79.64 | -- | -228.02 | -- | -- | -- | 0.108 | -- | -65.09 | -- | -31.55 | -- | -- | -- |
Inotiv Inc | 552.74m | -71.29m | 52.20m | 1.96k | -- | 0.2514 | -- | 0.0944 | -2.77 | -2.77 | 21.44 | 8.00 | 0.6565 | 7.18 | 7.91 | 282,733.50 | -8.58 | -23.84 | -13.63 | -29.26 | 28.76 | 29.31 | -13.07 | -33.24 | 0.2744 | -0.0193 | 0.6476 | -- | 4.52 | 85.10 | 68.80 | -- | 83.64 | -- |
Rallybio Corp | 0.00 | -76.28m | 53.88m | 43.00 | -- | 0.5513 | -- | -- | -1.88 | -1.88 | 0.00 | 2.36 | 0.00 | -- | -- | 0.00 | -58.30 | -- | -62.32 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.87 | -- | -- | -- |
Aerovate Therapeutics Inc | 0.00 | -82.19m | 54.45m | 51.00 | -- | 0.58 | -- | -- | -3.03 | -3.03 | 0.00 | 3.26 | 0.00 | -- | -- | 0.00 | -71.09 | -- | -80.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
Data as of Jul 25 2024. Currency figures normalised to LAVA Therapeutics NV's reporting currency: US Dollar USD
13.99%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Redmile Group LLCas of 31 Mar 2024 | 2.07m | 7.89% |
Bruce & Co., Inc.as of 31 Mar 2024 | 771.87k | 2.94% |
Sphera Funds Management Ltd.as of 31 Mar 2024 | 367.58k | 1.40% |
Walleye Capital LLCas of 31 Mar 2024 | 154.67k | 0.59% |
Alpha Wave Global LPas of 31 Mar 2024 | 107.91k | 0.41% |
Two Sigma Investments LPas of 31 Mar 2024 | 82.03k | 0.31% |
PNC Bank, NA (Investment Management)as of 31 Mar 2024 | 65.00k | 0.25% |
Millennium Management LLCas of 31 Mar 2024 | 20.03k | 0.08% |
Schonfeld Strategic Advisors LLCas of 31 Mar 2024 | 18.30k | 0.07% |
Two Sigma Advisers LPas of 31 Mar 2024 | 16.70k | 0.06% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.